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Abstract
Background:  P53 is a key tumor suppressor protein. In response to DNA damage, p53
accumulates to high levels in differentiated cells and activates target genes that initiate cell cycle
arrest and apoptosis. Since stem cells provide the proliferative cell pool within organisms, an
efficient DNA damage response is crucial.
Results: In proliferating embryonic stem cells, p53 is localized predominantly in the cytoplasm.
DNA damage-induced nuclear accumulation of p53 in embryonic stem cells activates transcription
of the target genes mdm2,  p21,  puma  and noxa. We observed bi-phasic kinetics for nuclear
accumulation of p53 after ionizing radiation. During the first wave of nuclear accumulation, p53
levels were increased and the p53 target genes mdm2,  p21  and  puma  were transcribed.
Transcription of noxa correlated with the second wave of nuclear accumulation. Transcriptional
activation of p53 target genes resulted in an increased amount of proteins with the exception of
p21. While p21 transcripts were efficiently translated in 3T3 cells, we failed to see an increase in
p21 protein levels after IR in embryonal stem cells.
Conclusion: In embryonic stem cells where (anti-proliferative) p53 activity is not necessary, or
even unfavorable, p53 is retained in the cytoplasm and prevented from activating its target genes.
However, if its activity is beneficial or required, p53 is allowed to accumulate in the nucleus and
activates its target genes, even in embryonic stem cells.
Background
Cells are continuously subjected to DNA lesions arising
both from environmental conditions and from the intrin-
sic metabolism of a cell. Such lesions can lead to muta-
tions and large-scale genome alterations that may be
deleterious for cellular function. To maintain genomic
stability cell cycle checkpoints exist that can detect errors
during DNA replication. If errors are encountered, cell
division is paused and repair mechanisms and/or cell
death ensues. The p53 tumor suppressor protein plays an
important role in this process [1]. By being part of a signal
transduction process, p53 relays information leading to
cellular responses such as cell cycle arrest and apoptosis,
resulting from DNA lesions. P53 activity is regulated
mainly at the protein level. In response to DNA lesions,
p53 is rescued from targeted degradation, which leads to
a strong increase in the amount of the otherwise short-
lived tumor suppressor protein, and the protein is inten-
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sively modified [2,3]. Cells deficient in p53 fail to
undergo apoptosis or cell cycle arrest in response to DNA
damage [4,5] which increases the rates of tumorigenicity
and genomic instability in these animals [6-8].
Pluripotent, undifferentiated embryonic stem (ES) cells
retain the potential to produce any cell type in the body
and contribute to all adult cell lineages. While mutations
in a somatic cell are limited to a particular lineage and do
not affect progeny, ES cell mutations potentially compro-
mise multiple lineages and affect the well-being of subse-
quent generations. As such, ES cells should have a highly
sensitive and finely tuned response to DNA damage. In
fact, previous reports described a reduction of mutation
frequency by about two orders of magnitude in ES cells
and a strongly enhanced sensitivity to ionizing radiation
(IR) and other DNA damaging agents [9-12]. Because of
the prominent role that p53 has in the DNA damage
response of differentiated cells, it is most likely that p53
has a similar function in stem cells. Indeed, it has been
reported that p53 deficiency increases the teratogenicity of
mice after administration of benzo[a]pyrene or after irra-
diation [13,14].
Despite previous research, it is still unclear whether p53 is
activated or not in stem cells in response to DNA damage.
While Yang Xu and co-workers found that p53 levels are
increased in response to DNA damage in ES cells and
mdm2 and noxa are expressed after irradiation of ES cells
with UV-light or treatment with doxorubicin, Mirit Alad-
jem observed that p53 failed to activate a stress response
in ES cells after treatment with PALA, IR or adriamycin
despite the accumulation of the tumor suppressor protein
in the nucleus of DNA-damaged ES cells, [15,16].
To clarify about the role of p53 in ES cells, we investigated
p53 localization and activity in resting ES cells and in ES
cells subjected to DNA damage in more detail. Similar to
Mirit Aladjem and co-workers [16], we found the majority
of p53 localized in the cytoplasm of proliferating ES cells.
However, after irradiation, p53 accumulated in the
nucleus. Nuclear accumulation of p53 in irradiated stem
cells correlated with the activation of mdm2, p21, noxa and
puma and the suppression of nanog.
Results
P53 is localized to the cytoplasm of mouse ES cells
In an attempt to resolve the caveat whether p53 is active
or not in stem cells, we first determined the localization of
the p53 protein in mouse ES cells. We investigated three
different mouse ES cell lines, R1, D3 and CGR8 and deter-
mined p53 localization by immuno-fluorescence stain-
ing. R1 and D3 cells were cultured on feeder cells while
CGR8 stem cells do not require feeders for maintaining an
undifferentiated phenotype. In consistency with a previ-
ous report [16], we found the majority of p53 localized in
the cytoplasm (Figure 1A, Additional file 1). These results
however do not exclude the possibility that a small frac-
tion of p53 exists in the nucleus.
Since some p53 isoforms have been shown to be cytoplas-
mic [17], we wondered whether p53 might show cytoplas-
mic localization in murine ES cells because of the
expression of particular cytoplasmic isoform of p53. How-
ever, both RT-PCR and Western Blotting with a polyclonal
Cytoplasmic localisation of p53 in proliferating ES cells Figure 1
Cytoplasmic localisation of p53 in proliferating ES 
cells. R1, D3 and CGR8 mouse embryonal stem cells were 
plated on cover slips (R1 and D3 in the presence of feeders, 
CGR8 in the absence of feeders). Two days after plating, cells 
were fixed in acetone/methanol, permeabilized with Triton-
X-100 and incubated with the anti-p53 antibody Pab 421. 
After incubation, cover slips were washed and incubated 
with an antibody directed against mouse IgG, coupled to 
Alexa-Fluor-488 (green). To visualize the nuclei, cover slips 
were incubated with Draq5 (blue). (B) R1 ES cells were 
transfected with RGC-lacZ or with a vector control together 
with GFP to visualize transfection efficiency. Two days after 
transfection, cells were fixed with paraformaldehyde and 
incubated with X-gal in reaction buffer to monitor β-galac-
tosidase expression. Arrows point to lacZ expressing R1 
cells.BMC Cell Biology 2009, 10:46 http://www.biomedcentral.com/1471-2121/10/46
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anti-murine p53 antiserum, detected a single strong band
for p53. This band migrated app. with the 53 kDa marker
in SDS gels and with the 1200 bp marker in agarose gels
(Additional file 2). Only upon longer exposures, smaller
bands became visible. Whether these smaller bands repre-
sent authentic splice products of p53 or whether they only
show cross-reactivity with other factors remains to be elu-
cidated.
As a transcription factor, p53 usually needs to be nuclear
to be active. Because of its cytoplasmic expression, we
wondered whether p53 would be able to activate tran-
scription of its target genes in ES cells. To test this possibil-
ity we transfected R1 ES cells with a cDNA encoding the
lacZ gene under the control of the p53-responsive RGC
promoter [18] and determined expression of β-galactosi-
dase. For monitoring transfection efficiency, we co-trans-
fected a cDNA encoding the green fluorescent protein
(GFP). Only a few cells showed β-galactosidase expression
(Figure 1B). Likewise, only a few cells showed expression
of GFP which indicates that a minority of stem cells had
been transfected. Since staining for GFP and X-gal corre-
sponded in numbers, it is most likely that all transfected
ES cells express β-galactosidase under the control of p53.
P53 becomes activated in ES cells after DNA damage
One particularly important function of p53 is DNA dam-
age signaling [4,5]. Here, to suppress tumorigenesis, p53
halts the cell cycle and induces apoptosis in primary cells
and in tumor cell lines. Since stem cells provide the pool
of proliferative pluri/toti/omni-potent cells within organ-
isms, they are more likely to propagate DNA lesions and
mutations to daughter cells compared to differentiated
cells. We therefore speculated that p53 has an important
role in the DNA damage response of stem cells. Since p53
is primarily a transcription factor, nuclear localization of
p53 should be essential for its transcriptional activity. This
activity is, however, not consistent with the cytoplasmic
localization of the tumor suppressor protein in ES cells.
One possibility could be that despite its cytoplasmic local-
ization in non-stressed ES cells, p53 accumulates in the
nucleus of ES cells after DNA damage. We tested this pos-
sibility after irradiation with both IR and UV light. As we
show already in figure 1, in unstressed ES cells p53 was
localized mainly to the cytoplasm. However, at one hour
after irradiation, p53 accumulated in the nucleus of irradi-
ated ES cells (Figure 2A, B). At four hours after irradiation,
p53 was still present in the nucleus of some cells, while in
others it had mostly disappeared. At eight hours after irra-
diation p53 had essentially disappeared from the nucleus
of all cells. Surprisingly, at 24 hours after IR, p53 was
again localized in the nucleus of most cells. Nevertheless,
a minority of cells still showed cytoplasmic localization of
p53 (Figure 2A, B). The same biphasic accumulation of
p53 in the nucleus of irradiated cells was also observed in
the CGR8 stem cell line (data not shown).
After UV-irradiation, p53 also accumulated in the nucleus
of ES cells. In contrast to IR-irradiated cells, p53 remained
in the nucleus of UV-irradiated cells. At 24 hours, most of
the ES cells had died while the few remaining ones
showed a very intensive nuclear staining for p53 (Figure
2C).
After having observed that p53 accumulates in the nucleus
of irradiated ES cells, we used qRT-PCR and Western Blot-
ting to test whether p53 activated transcription of its target
genes. To prevent contamination by feeder cells, ES cells
were sub-cultured once (P1) or twice (P2) without feeder
cells. Since ES cells were sub-cultured every day, P2 cells
had been cultured without feeders for only two days. To
exclude the possibility of premature differentiation in the
absence of feeder cells, we monitored expression of nanog
and oct 4 at the RNA and protein level (Figure 3A, B) and
of alkaline phosphatase (data not shown). Although P2
cells were hardly contaminated with feeder cells, we addi-
tionally determined expression of p53 target genes in
feeder cells. We further included 3T3 mouse fibroblasts in
the analysis in order to compare the regulation of p53 tar-
get genes in ES cells with that of differentiated cells. To
exclude artifacts due to culture conditions, we also
included ES (P2) cells that had not been irradiated but
were plated and harvested at the same time as irradiated
cells. As we show in figure 3A, the accumulation of p53 in
the nucleus of irradiated ES cells (compare Figure 2A) was
accompanied by a strong increase in the amount of p53
protein. Shortly after the accumulation of p53 protein lev-
els, Mdm2 and Puma proteins levels also increased. Con-
sistent with a previous report [16], the amount of p21
protein was very low in stem cells and was not increased
after irradiation. Likewise, we failed to detect an increase
in the amount of Bax protein. We also observed an
increase in the amount of Noxa protein, but only at 24
hours and induction was very low. Consistent with the
study by Lin and co-workers [15], we found that Nanog
protein was slightly reduced after DNA damage, but recov-
ered to basal levels eight hours after irradiation (Figure
3A). In non-irradiated R1 cells, the levels of the investi-
gated proteins remained unchanged throughout the
experiment (Figure 3A). In comparison to ES cells, 3T3
cells showed slightly different kinetics of p53 induction
after IR. Here, we observed the strongest induction at one
hour after irradiation. Consistent with a more important
role of p53 for the maintenance of genomic integrity in
stem cells than in differentiated cells, the overall induc-
tion of p53 was much higher in ES cells than in 3T3 cells.
Like in ES cells, the increase in the amount of p53 in 3T3
cells was followed by an increase in the amount of the
Mdm2 and the p21 protein. The amount of the p21 pro-BMC Cell Biology 2009, 10:46 http://www.biomedcentral.com/1471-2121/10/46
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p53 accumulates in the nucleus of irradiated ES cells Figure 2
p53 accumulates in the nucleus of irradiated ES cells. R1 (A, C) and D3 (B) stem cells, grown on feeders, were irradi-
ated two days after plating with 7.5 Gray IR (A, B) or with 30 J/m2 UVC light (C) and harvested at the indicated times. Cells 
were fixed in acetone/methanol, permeabilized with Triton-X-100 and incubated with the anti-p53 antibody Pab 421. After 
incubation, cover slips were washed and incubated with an antibody directed against mouse IgG, coupled to Alexa-Fluor-488 
(green). To visualize the nuclei, cover slips were incubated with Draq5 (blue).BMC Cell Biology 2009, 10:46 http://www.biomedcentral.com/1471-2121/10/46
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p53 is activated in ES cells after IR Figure 3
p53 is activated in ES cells after IR. R1 stem cells passaged once (P1) or twice (P2) without feeders and 3T3 mouse fibrob-
lasts were irradiated with 7.5 Gray or left unirradiated. Cells were harvested at the indicated times and divided into two aliq-
uots. One of the aliquots was used to determine the amount of protein (A) and the second aliquot (B) to monitor the 
abundance of corresponding RNAs. (A) Western Blots showing p53, p21, Bax, Noxa, Mdm2, Puma, Oct4, Nanog and PCNA 
(proliferating cell nuclear antigen) for loading control. (B) Real time PCR for mdm2, p21, puma, noxa, bax, oct4 and nanog RNA. 
Mean values and standard deviations were calculated from the obtained 2^dCT numbers of qRT-PCR signals of 3–6 independ-
ent experiments and blotted. Values of non-irradiated P2 cells at time point "0" and non-irradiated 3T3 cells, respectively, were 
set to 1. The quality of the qRT-PCR products was controlled by agarose gel electrophoresis. A representative picture of the 
gel is placed below the graph.BMC Cell Biology 2009, 10:46 http://www.biomedcentral.com/1471-2121/10/46
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tein was also very high in feeder cells which have been
irradiated prior to the plating of the cells, suggesting that
p21 levels may remain high for several days after irradia-
tion. As expected, we failed to detect Nanog and Oct-4
proteins in 3T3 cells (Figure 3A). The determination of the
amount of proteins was complemented by qRT-PCR. To
allow a direct comparison of the expression of p53 target
genes at the RNA and protein level, we performed qRT-
PCR on a second aliquot of the same lot of cells that had
been used for Western Blot analysis. The analysis of the
PCR products by agarose gel electrophoresis revealed sin-
gle bands in all cases (Figure 3B). It should, though, be
noted that the analysis of the PCR products by agarose gel
electrophoresis was not quantitative. The analysis of gene
expression by qRT-PCR essentially mirrored results from
Western blotting, with two exceptions: While the p21 pro-
tein was hardly detectable in stem cells and its amount
was not increased after IR, we observed p21 RNA in stem
cells at a level that was almost comparable with the
amount of p21 RNA in 3T3 cells. Moreover, the amount of
p21 RNA was further increased in response to IR in ES
cells. Another difference between protein and RNA analy-
sis was observed for Puma. While Western blotting dis-
played a similar increase in the amount of Puma in 3T3
and ES cells, puma RNA was induced about 2-fold stronger
in 3T3 cells than in ES cells. Like the protein, mdm2 RNA
accumulated transiently in both ES and 3T3 cells. How-
ever, maximum mdm2 induction in 3T3 cells occurred ear-
lier (Figure 3B), consistent with the earlier increase in p53
protein abundance (Figure 3A). Consistent with the sec-
ond phase of nuclear accumulation of p53, we observed
induction of the p53 target gene noxa at twenty-four hours
after irradiation in ES cells while we failed to detect
expression of noxa in 3T3 cells, despite its expression in
feeder cells. We also failed to detect an increase in the
expression of bax RNA both in ES cells and in 3T3 cells.
Both stem cell markers, oct 4 and  nanog  were highly
expressed in ES cells but clearly reduced (nanog) or absent
(oct 4) in differentiated cells. After irradiation, the amount
of nanog RNA was slightly reduced in ES cells but not in
3T3 cells (Figure. 3B).
Influence of p53 on proliferation and survival of ES cells 
after ionising radiation
After showing that p53 accumulates in the nucleus and
activates transcription of its target genes, we wondered
whether the presence of p53 might be required for a nor-
mal DNA damage response in ES cells. To address this
question, we first compared the colony forming ability of
R1 ES cells with that of R1 ES cells where p53 activity was
inhibited by treatment with α- or μ-pifithrin [19,20]. As
we show in figure 4A, irradiation reduced the colony
forming ability of R1 ES cells in a dose dependent man-
ner. Treatment with pifithrin further sensitized the ES cells
to IR, suggesting a protective effect of p53. To further
investigate this protective effect, we repeated the colony
forming assay with p53-negative ES cells (p53-/-) and the
corresponding parental cell line (D3). Both cell lines
showed a dose dependent decrease in their colony form-
ing ability after IR. The sensitivity of D3 cells and the p53-
negative derivatives to irradiation, though, appeared to be
significantly stronger than that of R1 cells and the size of
the individual colonies varied significantly after irradia-
tion in both D3 cells and the p53-negative derivative. A
protective effect of p53 was, however, not discernable
(Figure 4B).
In apoptotic cells, the membrane-phospholipid phos-
phatidylserine is translocated from the inner to the outer
surface of the plasma membrane, thereby exposing phos-
phatidylserine to the external cellular environment. The
phospholipid-binding protein Annexin-V, which has a
high affinity for the phospholipid binds to those cells that
expose phosphatidylserine. This association of Annexin-V
with exposed phosphatidylserine is a sensitive and widely
accepted method for the determination of apoptosis. We
applied this method to determine the influence of p53 on
the initiation of apoptosis of irradiated ES cells. To pre-
vent contamination, we performed this assay with ES cells
that have been passaged once without feeder cells (P1
cells). Under these conditions, we observed no signs of
apoptosis with p53-positive D3 cells while p53-negative
cells showed a slight increase in the number of apoptotic
cells at 48 hours after irradiation (Figure 4C). Neverthe-
less, the increase was still within the error bars of non-irra-
diated cells and unexpectedly low. We also performed this
analysis with cells that had been passaged twice without
feeders (P2 cells). Under these conditions about twice as
many ES cells were Annexin-V-positive, even without irra-
diation (data not shown). This number of Annexin-V-pos-
itive ES cells was slightly increased after irradiation.
Nevertheless, the increase in Annexin-V positive cells after
irradiation never exceeded a factor of 3.5 (Additional file
3).
A widely used assay for the determination of relative cell
proliferation and cell viability is the colorimetric MTT-
assay, which determines the reduction of yellow (3-(4.5-
Dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide
to purple formazan by metabolic enzymes. We employed
this assay to determine relative cell proliferation and cell
viability of irradiated p53-positive and the corresponding
p53-negative ES cells. Surprisingly, p53-negative ES cells
derived from the D3 ES cell line proliferated slower and
reached a plateau at a lower cell density in comparison
with their parental counterpart. Irradiation had only a
minor impact on the proliferation of these p53-negative
ES cells and affected cell number only within the first 48
hours after irradiation. Thereafter, irradiated and non-irra-
diated p53-negative ES cells had a similar proliferationBMC Cell Biology 2009, 10:46 http://www.biomedcentral.com/1471-2121/10/46
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rate. Proliferation of the corresponding p53-positive ES
cell line was affected much more by radiation. Cell prolif-
eration of the D3 ES cell line was more strongly reduced
after irradiation and the proliferation rate was decreased
over several days (Figure 4D).
Discussion
Consistent with a previous report [16], we found p53
localized in the cytoplasm of ES cells. However, while
Mirit Aladjam and co-workers reported that p53 is inac-
tive in stem cells [16], we found that p53 activates tran-
scription of a reporter gene in resting ES cells and of
endogenous target genes in response to DNA damage. The
activity of p53 in resting stem cells shows that the p53
protein is also in ES cells in a latent state and can be acti-
vated when its activity is required. This result is consistent
with a study from Sabapathy et al., who observed binding
of p53 from ES cells to oligonucleotides corresponding to
Proliferation and apoptosis assays of ES cells in the presence and absence of active p53 Figure 4
Proliferation and apoptosis assays of ES cells in the presence and absence of active p53. (A) R1 cells were treated 
with 10 μM α-pifithrin, μ-pifithrin or carrier 24 hours after plating. Two hours after drug addition, cells were irradiated and 
after additional two hours, the medium was replaced with normal growth medium. After two weeks, colonies were counted. 
The graph shows mean values and standard deviations of three to six independent experiments. The number of colonies from 
non-irradiated cells was set to 100%. (B) D3 or p53-/- ES cells were irradiated with IR 24 hours after plating. After two weeks, 
colonies were counted. The graph shows mean values and standard deviations of three independent experiments. The number 
of colonies from non-irradiated cells was set to 100%. (C) P53-/- cells and D3 cells passaged once without feeders (P1 cells) 
were irradiated with 2 Gy and analysed for Annexin V staining after 24 and 48 hours. The graph shows the relative number and 
standard deviation of Annexin-V positive cells of three independent experiments. (D) D3 or p53-/- ES cells were irradiated 
with 2 Gray of IR and analysed at the indicated times by MTT assay. Mean values and standard deviations were calculated and 
plotted. The numbers for the two cell lines and conditions at day one were set to 1.BMC Cell Biology 2009, 10:46 http://www.biomedcentral.com/1471-2121/10/46
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the p53 consensus binding sequence [21]. After DNA
damage, p53 did not activate all, but at least some of its
target genes in ES cells. Transcription of these genes was
facilitated by the presence of active p53 in the nucleus of
irradiated cells. After IR, p53 accumulated in two waves in
the nucleus of ES cells. The first nuclear accumulation
occurred at one to two hours after irradiation and corre-
lated with an increase in the amount of the p53 protein.
During the second wave of nuclear accumulation of p53
at twenty-four hours after irradiation, we did not see an
increase in p53 abundance suggesting that for the second
wave of nuclear accumulation p53 was translocated from
the cytoplasm into the nucleus. Whether nuclear translo-
cation also contributed to the first wave of nuclear accu-
mulation of p53 is still unclear. Both waves of nuclear
accumulation of p53 corresponded to transcriptional acti-
vation of target genes. The first wave of nuclear accumula-
tion of p53 correlated with transcriptional activation of
mdm2, p21 and puma [22-24], while noxa [25] was tran-
scribed during the second wave of nuclear accumulation
of p53. Why some of the p53 target genes are transcribed
only during the first wave of nuclear accumulation and
why at least one other gene is transcribed only during the
second wave of nuclear accumulation is presently unclear.
It may be that distinct post-translational modifications of
p53 are induced with different kinetics after irradiation
and are required for the activation of different p53 target
genes [26].
Most surprisingly, p21 was actively transcribed in ES cells
and the amount of its RNA was increased further in
response to IR, while the protein was hardly detectable
before and after irradiation. This result indicates that pro-
duction of p21 protein is strongly regulated at a post-tran-
scriptional level in ES cells. Eventually, ES cells with
damaged DNA require efficient elimination from the pop-
ulation. Since G1 arrest triggered by p21 can prevent cells
from S-phase entry and thus from the cellular death pro-
gram that is executed in the S-phase of cells with damaged
DNA, e.g. by the activity of proteins such as Killin, the
presence of p21 might counteract this elimination
[27,28]. However, consistent with the results of Corbet et
al., we did not see a strong induction of apoptosis in ES
cells after ionizing radiation, as revealed by Annexin-V
staining [29] which argues against this possibility.
While we observed activation of the transcription of
mdm2, puma, noxa and p21, we failed to detect an activa-
tion of bax transcription [30] after IR. Probably, activation
of bax after DNA damage is restricted to specific cell types
that were not included in this study. Such a selectivity of
gene expression in different cell lines is known for several
years. For instance, it had been shown that γ-irradiation
leads to a prolonged cell cycle arrest in fibroblasts whereas
the same challenge leads to apoptosis in thymocytes and
intestinal epithelial cells [31-34].
Overall, the impact of p53 on the response of murine ES
cells to ionizing radiation was surprisingly low. The com-
parison of p53-positive and p53-negative stem cells of the
same background showed basically identical colony form-
ing abilities after DNA damage. Only when we treated the
R1 ES cell line with chemical inhibitors of p53, we
observed a slightly decreased survival in the presence of
the drug. Since this result could not be reproduced with
p53-positive and p53-negative ES cell lines, the increased
sensitivity of R1 ES cells in the presence of μ- or α-pifithrin
is most likely due to off-target effects. It should though be
noted that Corbet et al., although they also found only
very little induction of apoptosis after irradiation of ES
cells with IR, reported a more pronounced reduction in
the colony forming ability of p53-positive ES cells after IR
than of p53-negative cells [29]. The reason for the discrep-
ancy of our result and the result from Corbet is unclear.
However, since the ES cell lines that were used by Corbet
et al., and the ones that we used are not identical, it is
likely that the different results are due to a variation in
intrinsic cellular paramaters. Only when we applied the
MTT assay, we observed a slight difference between p53-
positive and p53-negative ES cells after irradiation. How-
ever, this result should be taken with care. First of all, the
MTT-assay is a metabolic assay and conditions that affect
cell metabolism can impact on the result. Secondly, p53-
negative cells showed a significantly reduced proliferation
(or metabolic) behavior compared to the p53-positive
parental cell line. This different proliferation behavior
could also affect the outcome of the assay.
While p53 is predominantly a nuclear protein in differen-
tiated cells, in ES cells p53 is mostly cytoplasmic. The
rational for this aberrant localization of p53 in ES cells is
still unclear. However, since p53 suppresses nanog expres-
sion as well as self-renewal of adult neural stem cells
[15,35] it is possible that p53 needs to be separated from
the nucleus of ES cells to maintain an undifferentiated
phenotype. By sequestering p53 to the cytoplasm, p53 is
unable to suppress nanog while, at the same time, suffi-
cient latent p53 protein is present in ES cells to enter the
nucleo-cytoplasmic barrier when required.
Conclusion
Our study clearly shows that p53 can be activated in stem
cells despite its cytoplasmic localisation. However, results
for p53 activation in stem cells depend on the selection of
genes that are analyzed and whether the analysis is per-
formed at the RNA or protein level.
Whether p53 activity is required for the DNA damage
response of ES cells cannot be answered that easily. Over-BMC Cell Biology 2009, 10:46 http://www.biomedcentral.com/1471-2121/10/46
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all, we found only a minor effect of p53 activity on prolif-
eration and survival of ES cells after ionizing irradiation.
The analysis, however, also shows that in dependence on
what method is used, the result can vary.
Methods
Cell lines and their treatments
R1 and D3 ES cells were cultured in GlutaMAX™-I
medium (Invitrogen) supplemented with 15% foetal
bovine serum, 0.1 mM β-mercaptoethanol, 40 μg/ml gen-
tamycin and 1000 units/ml LIF in culture dishes that had
been coated with 0.1% gelatine. Mouse embryonal fibrob-
lasts that had been irradiated with 6.3 Gray served as
feeder cells. p53-/- ES cells were cultured in GlutaMAX™-I
medium (Invitrogen) supplemented with 15% foetal
bovine serum, 0.1 mM β-mercaptoethanol, 1000 units/ml
LIF and 300 μg/ml G418 in culture dishes that had been
coated with 0.1% gelatine. SNL cells irradiated with 6.3
Gray served as feeder cells. CGR8 cells were grown in Glas-
gow Minimum Essential Medium (Sigma) supplemented
with 10% foetal bovine serum, 40 μg/ml gentamycin, 100
units/ml LIF, 0.05 mM β-mercaptoethanol, 2 mM L-
glutamine and 1 mM non-essential aminoacids without
feeder cells. Culture dishes were coated with 0.2% gela-
tine. All ES cell lines were sub-cultured each day. 3T3 cells
were grown in Dulbecco's Modified Eagle Medium (Invit-
rogen) supplemented with 10% donor bovine serum
(Invitrogen) and 1% penicillin/streptomycin (Invitro-
gen). All cells were cultured at 37°C and 6% CO2 in a
humidified atmosphere.
Cells were irradiated with a 60cobalt γ-ray source at a dose
rate of 1 Gray per minute in cell culture medium. For UV-
irradiation, the culture medium was removed and saved.
The cells were washed with PBS and irradiated with 30 J/
m2. After irradiation, the original culture medium was
added back to the cells.
Transfections were performed using the mouse ES cell
Nucleofector Kit (Amaxa) according to the manufacturer's
recommendations.
Antibodies
The mouse monoclonal anti-p53 antibody Pab421 was
purchased from Biomol, the rabbit polyclonal anti-p53
antibody CM5 was bought from Vector Laboratories, the
mouse monoclonal anti-Mdm2 antibody 4B2 was
obtained from Calbiochem and the rabbit polyclonal
anti-Bax and anti-Puma antibodies were from Cell Signal-
ling. Antibodies targeted against p21 (C-19), Noxa (K-
16), Oct-4 (C-10) and PCNA (PC10) were purchased
from Santa Cruz. The antibody directed against Nanog
was obtained from Millipore. Alexa-488 goat anti-mouse
antibody (Invitrogen) and HRP-coupled goat anti-mouse
and goat anti-rabbit antibodies (Dako) were used as sec-
ondary antibodies.
SDS-PAGE and Western blotting
SDS-PAGE and Western blotting were performed as
described [36].
Immunofluorescence staining
ES cells were grown on feeder cells that had been grown
on cover slips. After washing twice with ice cold PBS, cells
were fixed with ice-cold acetone/methanol (1:1) for 8 min
on ice. Cover slips were washed 3 times with PBS and cells
were permeabilized with 0.5% Triton-X-100 in PBS for 10
min. Cover slips were washed 3 times with PBS and incu-
bated for 30 min in blocking buffer (1% bovine serum
albumin; 1% goat serum in PBS). After blocking, cells
were incubated overnight with an antibody directed
against p53 (Pab421) that had been diluted 1:200 in
blocking buffer. Cover slips were washed 3 times with PBS
and incubated for 30 min at room temperature in the dark
with an antibody directed against mouse IgG coupled to
Alexa-Fluor-488 (Invitrogen) and Draq 5 (Biostatus Lim-
ited) both diluted 1:1000 in blocking buffer. Cover slips
were washed 3 times and mounted with Hydromount on
microscope slides. Cells were analysed using a Zeiss
LSM510 confocal microscope and LSM LSell5 Image
Examiner software.
RT-PCR
Total RNA was prepared from cells using the RNeasy kit
(Qiagen) according to the manufacturer's recommenda-
tion and treated with DNase I to remove residual genomic
DNA. RNA was transcribed into cDNA using random
primers and RevertAidtm H MinusM-MuLV reverse tran-
scriptase (Fermentas). Real-time PCR was performed in
duplicates with a SYBR Green PCR mixture (Qiagen). The
cDNA was denatured for 15 min at 95°C followed by 40
cycles of 95°C for 15 s and 50°C for 1 min using the 7000
ABI sequence detection system and gene specific primers.
The signals were normalized to the signals for the house-
keeping gene 34B4. Sequences of primers are available on
request.
Beta-Galactosidase staining
Cells were washed with PBS and fixed with 3.5% parafor-
maldehyde in PBS for 10 min on ice. Cells were washed 3
times with PBS, incubated with X-gal (0.25 mg/ml) and
solubilised in reaction buffer (5 mM potassium ferricya-
nide, 5 mM potassium ferrocyanide, 2 mM magnesium
chloride in PBS) for 16 h at 37°C. Cells were analysed
with a Zeiss Axiovert microscope.
MTT-assay
106 D3 cells or p53-/- cells were plated on 0.1% gelatine-
coated 6 cm-plates. After attachment, cells were irradiatedBMC Cell Biology 2009, 10:46 http://www.biomedcentral.com/1471-2121/10/46
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with 2 Gray or left unirradiated for control. Each day, MTT
(3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
Bromide) was added to two plates at a final concentration
of 2.5 mg/ml and incubated for 4 h. The reaction was
stopped by removal of the medium and solubilization of
the MTT-precipitate in 2 ml isopropanol. Absorbances
were read at 595 nm.
Colony assay
200 ES cells were plated in 3.5 cm dishes coated with
0.2% gelatine. Twenty-four hours after plating α-pifithrin
and μ-pifithrin were added to a final concentration of 10
μM. Two hours after drug addition, cells were irradiated
with 0.5 Gy, 1 Gy, 2 Gy and 4 Gy. After additional two
hours, the culture medium was replaced with fresh
medium without inhibitors and the cells were incubated
for two weeks with a daily change of culture medium. The
cells were washed with PBS, fixed with methanol, stained
with 1% crystal violet in PBS and counted. For colony
assays in the absence of an inhibitor, cells were irradiated
at four hours after plating and incubated for two weeks
with a daily change of culture medium.
Apoptosis Assay by Annexin V staining
1 × 106 D3 or p53-/- ES cells were washed with ice-cold
PBS and resuspended in 400 ml Ca-containing buffer (10
mM HEPES, pH 7.4, 140 mM NaCl, 5 mM CaCl2). 5 μl of
annexin V-FITC (BD Pharmingen) and 1 μg propidium
iodide were added for 10 min and the cells were immedi-
ately analyzed by a BD FACScan Flow Cytometer (Becton
Dickinson).
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